Peritoneal carcinomatosis is the most common pattern of recurrence of gastric cancer, and it is important to identify patients at high risk for recurrence. Although the carcinoembryonic antigen level in peritoneal lavage (pCEA) was reported to be a useful biomarker to predict peritoneal recurrence in a small series, its clinical significance has not been fully validated. We evaluated the clinical significance of pCEA in a large cohort of patients with gastric cancer.
We prospectively analyzed the pCEA level in 597 patients with histologically proven gastric cancer who underwent laparotomy.
A significant relationship was demonstrated between the value of pCEA and clinicopathologic features, such as the peritoneal lavage cytology, peritoneal metastasis, the depth of tumor invasion, and the lymph node metastasis. The cutoff value was set at 100 ng/g of protein, and 134 of the 462 patients who underwent curative surgery had positive pCEA findings. The overall and the intraperitoneal-recurrence-related survival of patients positive for pCEA were significantly poorer than those of pCEA-negative patients. When we analyzed the patients with pathologic stage I through III gastric cancers separately, the pCEA-positive patients had poorer prognoses than the pCEA-negative patients who had stage III gastric cancer. In a univariate analysis, the tumor size, depth of tumor invasion, lymph node metastasis, histologic type, serum CEA (sCEA), and pCEA were found to affect the patients' outcomes, although a multivariate analysis found only the extent of lymph node metastasis to be an independent prognostic factor.
The pCEA level is a useful biomarker to predict gastric cancer-related death. Moreover, the pCEA level may be useful to identify a cohort of patients with gastric cancer who need more intensive adjuvant chemotherapy to improve their prognoses.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry.Gastric Cancer. 2011; 14: 301-316
- Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial.Ann Surg. 2005; 241: 232-237
- A multicenter retrospective study of endoscopic resection for early gastric cancer.Gastric Cancer. 2006; 9: 262-270
- Treatment options for surgically resectable gastric cancer.Curr Treat Options Oncol. 2010; 11: 14-23
- Adjuvant therapy in gastric cancer.J Clin Oncol. 2005; 23: 6220-6232
- Recurrence following curative resection for gastric carcinoma.Br J Surg. 2000; 87: 236-242
- Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer.Cancer. 1991; 68: 44-47
- Prognostic significance of peritoneal washing cytology in patients with gastric cancer.Br J Surg. 2012; 99: 397-403
- The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.Ann Surg Oncol. 2010; 17: 1471-1474
- Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer.Am J Surg. 2001; 181: 356-361
Japanese classification of gastric carcinoma, 3rd Eng. ed. Gastric Cancer 2011;14:101-12.
- Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer.Am J Surg. 2006; 192: 185-190
- Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.Clin Chem. 1993; 39: 561-577
- Quantitative detection of disseminated cancer cells in the greater omentum of gastric carcinoma patients with real-time RT-PCR: a comparison with peritoneal lavage cytology.Gastric Cancer. 2002; 5: 69-76
- Assessment of the exfoliation of tumor cells into the body cavities.Surg Gynecol Obstet. 1961; 112: 469-474
- Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.Clin Cancer Res. 2003; 9: 678-685
- Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature.Cancer. 1993; 72: 3174-3178
- Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites.Br J Cancer. 2002; 87: 1153-1161
- Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer.Br J Surg. 1996; 83: 672-674
- Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.Ann Surg. 1998; 227: 372-379
- Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.Am J Surg. 1999; 178: 256-262
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer.Br J Surg. 1990; 77: 436-439
- Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome.J Surg Oncol. 1995; 59: 226-229
- Peritoneal lavage cytology findings as prognostic factor for gastric cancer.Semin Surg Oncol. 1999; 17: 103-107
- Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells.J Am Coll Surg. 1997; 184: 611-617
- Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.World J Surg. 1995; 19 (discussion 7): 133-137
- Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer.Oncol Rep. 1998; 5: 661-666
- Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer.Gastric Cancer. 1999; 2: 1-7
- Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.J Cancer Res Clin Oncol. 2007; 133: 471-476
- Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.Cancer Lett. 2005; 223: 129-135
- Peritoneal carcinoembryonic antigen level for predicting locoregional and distant spread of gastric cancer.Surg Today. 2005; 35: 919-924
- Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.World J Gastroenterol. 2005; 11: 7374-7377
- Levels of carcinoembryonic antigen and CA19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma.Arq Gastroenterol. 2008; 45: 219-224
- Serum carcinoembryonic antigen levels and proliferating cell antigen labeling index for patients with colorectal carcinoma.Cancer. 1996; 77: 1741-1746
- The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.J Cancer Res Clin Oncol. 2010; 136: 517-526
- Prognostic significance of peritoneal minimal residual disease in gastric cancer detected by reverse transcription-polymerase chain reaction.Br J Surg. 2004; 91: 435-443
- Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: analysis of real-time reverse transcriptase-polymerase chain reaction after 5 years of follow-up.J Am Coll Surg. 2006; 202: 231-236
- Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives.Gastric Cancer. 2007; 10: 197-204
- Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.Cancer. 2005; 103: 358-367
- When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?.World J Surg. 2005; 9: 1131-1134
- Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.Anticancer Drugs. 1996; 7: 548-557
- Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.N Engl J Med. 2007; 357: 1810-1820
Published online: June 27, 2013
Accepted: March 13, 2013
© 2013 Mosby, Inc. Published by Elsevier Inc. All rights reserved.